The Oncology Institute, Inc.
NASDAQ:TOI
2.5 (USD) • At close April 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 49.669 | 33.488 | 14.01 | 114.299 | 5.998 | 2.446 |
| Short Term Investments
| 0 | 49.367 | 59.796 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 49.669 | 82.855 | 73.806 | 114.299 | 5.998 | 2.446 |
| Net Receivables
| 48.681 | 42.911 | 40.433 | 21.244 | 17.259 | 14.734 |
| Inventory
| 10.039 | 13.678 | 9.261 | 6.438 | 4.354 | 3.889 |
| Other Current Assets
| 4.029 | 4.049 | 6.918 | 12.075 | 2.109 | 0.723 |
| Total Current Assets
| 112.418 | 143.493 | 130.506 | 154.056 | 29.72 | 21.793 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 37.67 | 40.052 | 33.041 | 4.192 | 2.104 | 1.551 |
| Goodwill
| 7.23 | 7.23 | 23.414 | 26.626 | 14.227 | 14.077 |
| Intangible Assets
| 14.81 | 17.904 | 17.957 | 18.245 | 19.516 | 22.003 |
| Goodwill and Intangible Assets
| 22.04 | 25.134 | 41.371 | 44.871 | 33.742 | 36.079 |
| Long Term Investments
| 0 | 0 | 58.354 | -0.371 | -2.121 | 0 |
| Tax Assets
| 0 | 0 | 0.108 | 0.371 | 2.121 | 0 |
| Other Non-Current Assets
| 0.589 | 0.561 | 0.369 | 0.32 | 0.123 | 0.098 |
| Total Non-Current Assets
| 60.299 | 65.747 | 133.243 | 49.383 | 35.969 | 37.728 |
| Total Assets
| 172.717 | 209.24 | 263.749 | 203.439 | 65.689 | 59.521 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 24.324 | 14.429 | 9.372 | 15.559 | 12.643 | 8.885 |
| Short Term Debt
| 6.798 | 6.363 | 5.498 | 0.183 | 5.368 | 0 |
| Tax Payables
| 0 | 0 | 0.387 | 0.132 | 1.144 | 0.489 |
| Deferred Revenue
| 0 | 0.545 | 1.139 | 0.592 | 3.379 | 0 |
| Other Current Liabilities
| 21.093 | 13.451 | 13.324 | 13.332 | 6.073 | 4.211 |
| Total Current Liabilities
| 52.215 | 34.788 | 29.853 | 29.798 | 28.607 | 13.585 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 23.223 | 113.312 | 102.868 | 0 | 6.561 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0.032 | 0.032 | 0.554 | 0.371 | 1.613 | 2.957 |
| Other Non-Current Liabilities
| 93.658 | 4.083 | 5.902 | 69.482 | 0.807 | 3.713 |
| Total Non-Current Liabilities
| 116.913 | 117.427 | 109.216 | 69.482 | 8.98 | 3.713 |
| Total Liabilities
| 169.128 | 152.215 | 139.069 | 99.28 | 37.587 | 17.298 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 80.114 | 48.143 |
| Common Stock
| 0.008 | 0.008 | 0.007 | 0.007 | 0.006 | 0.001 |
| Retained Earnings
| -210.813 | -146.15 | -61.577 | -63.234 | -52.307 | -6.015 |
| Accumulated Other Comprehensive Income/Loss
| 0 | -0 | -0 | 0 | -0.006 | -0.001 |
| Other Total Stockholders Equity
| 214.394 | 203.167 | 186.25 | 167.386 | 80.402 | 0.094 |
| Total Shareholders Equity
| 3.589 | 57.025 | 124.68 | 104.159 | 28.102 | 42.222 |
| Total Equity
| 3.589 | 57.025 | 124.68 | 104.159 | 28.102 | 42.222 |
| Total Liabilities & Shareholders Equity
| 172.717 | 209.24 | 263.749 | 203.439 | 65.689 | 59.521 |